ask="12.25"
ask_size="900"
average_daily_volume="9580"
bid="5.00"
bid_size="300"
book_value="2.91"
change="+0.03"
change_from_200_day_moving_average="-0.53"
change_from_50_day_moving_average="-0.61"
change_from_52_week_high="-4.53"
change_From_52_week_low="2.20"
change_in_percent="+0.32%"
close="9.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.64"
ebitda="0.00"
eps_estimate_current_year="-1.99"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="3574000"
high="9.53"
high_52_weeks="13.98"
last_trade_date="3/9/2017"
last_trade_price="9.45"
last_trade_size="100"
last_trade_time="3:59pm"
low="9.40"
low_52_weeks="7.25"
market_capitalization="87.60M"
moving_average_200_day="9.98"
moving_average_50_day="10.06"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.75"
open="9.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-5.31%"
percent_change_from_50_day_moving_average="-6.07%"
percent_change_from_52_week_high="-32.40%"
percent_change_from_52_week_low="+30.34%"
previous_close="9.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.24"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.23"
stock_exchange="NGM"
symbol="GEMP"
volume="2783"
weeks_range_52="7.25 - 13.98"
